Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Andriole

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Pennsylvania Medicine|May 1, 1987
Life imitates artG L Andriole, G L Andriole, D A Jablons
Seminars in Urology|May 1, 1993
The case for prostate cancer screeningG L Andriole
The Journal of Urology|February 26, 1999
Bladder cancer in the next millenniumG L Andriole
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
Serum prostate-specific antigen: the most useful tumor markerG L Andriole
European Urology|January 1, 1997
Adjuvant therapy for prostate cancer patients at high risk of recurrence following radical prostatectomyG L Andriole
Urology|October 13, 2001
Laparoscopic radical prostatectomy: CONG L Andriole
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Serum prostate-specific antigen: expanding its role as a measure of treatment response in patients with prostate cancerG L Andriole
Pennsylvania Medicine|June 1, 1990
Second opinion given on Canadian systemG L Andriole
The Journal of Urology|September 1, 1995
Prostate cancerG L Andriole
Cancer|July 18, 2000
The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinomaB I Carlin, G L Andriole
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Pennsylvania Medicine|May 1, 1987
Life imitates artG L Andriole, G L Andriole, D A Jablons
Seminars in Urology|May 1, 1993
The case for prostate cancer screeningG L Andriole
The Journal of Urology|February 26, 1999
Bladder cancer in the next millenniumG L Andriole
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
Serum prostate-specific antigen: the most useful tumor markerG L Andriole
European Urology|January 1, 1997
Adjuvant therapy for prostate cancer patients at high risk of recurrence following radical prostatectomyG L Andriole
Urology|October 13, 2001
Laparoscopic radical prostatectomy: CONG L Andriole
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Serum prostate-specific antigen: expanding its role as a measure of treatment response in patients with prostate cancerG L Andriole
Pennsylvania Medicine|June 1, 1990
Second opinion given on Canadian systemG L Andriole
The Journal of Urology|September 1, 1995
Prostate cancerG L Andriole
Cancer|July 18, 2000
The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinomaB I Carlin, G L Andriole
Pageof 10